Fatty acid-activated nuclear transcription factors and their roles in human placenta

European Journal of Lipid Science and Technology

Volumn 108, Issue 1, 2006, Pages 70-83

  Duttaroy, Asim K ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Fatty acid uptake; LXR; Placenta; PPAR; SREBR

Indexed keywords

EID: 32044456682     PISSN: 14387697     EISSN: 14389312     Source Type: Journal    
DOI: 10.1002/ejlt.200500272     Document Type: Review

References (144)

1. N. M. Gude, C. T. Roberts, B. Kalionis, R. G. King: Growth and function of the normal human placenta. Thromb Res. 2004, 114, 397-407.
2. A. K. Duttaroy: Fatty acid transport and metabolism in the feto-placental unit and the role of fatty acid-binding proteins. J Nutr Biochem. 1997, 8, 548-557.
3. K. K. Ong, D. B. Dunger: Perinatal growth failure: The road to obesity, insulin resistance and cardiovascular disease in adults. Best Pract Res Clin Endocrinol Metab. 2002, 16, 191-207.
4. Y. Barak, M. C. Nelson, E. S. Ong, Y. Z. Jones, P. Ruiz-Lozano, K. R. Chien, A. Koder, R. M. Evans: PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell. 1999, 4, 585-595.
5. E. B. Berry, R. Eykholt, R. J. Helliwell, R. S. Gilmour, M. D. Mitchell, K. W. Marvin: Peroxisome proliferator-activated receptor isoform expression changes in human gestational tissues with labor at term. Mol Pharmacol. 2003, 64, 1586-1590.
6. N. Z. Ding, C. B. Teng, H. Ma, H. Ni, X. H. Ma, L. B. Xu, Z. M. Yang: Peroxisome proliferator-activated receptor delta expression and regulation in mouse uterus during embryo implantation and decidualization. Mol Reprod Dev. 2003, 66, 218-224.
7. Y. Xu, T. J. Cook, G. T. Knipp: Effects of di-(2-ethylhexyl)-phthalate (DEHP) and its metabolites on fatty acid homeostasis regulating proteins in rat placental HRP-1 trophoblast cells. Toxicol Sci. 2005, 84, 287-300.
8. M. V. Chakravarthy, Z. J. Pan, Y. M. Zhu, K. Tordjman, J. G. Schneider, T. Coleman, J. Turk, C. F. Semenkovich: "New" hepatic fat activates PPAR alpha to maintain glucose, lipid, and cholesterol homeostasis. Cell Metab. 2005 1, 309-322.
9. H. Glosli, O. A. Gudbrandsen, A. J. Mullen, B. Halvorsen, T. H. Rost, H. Wergedahl, H. Prydz, P. Aukrust, R. K. Berge: Down-regulated expression of PPAR alpha target genes, reduced fatty acid oxidation and altered fatty acid composition in the liver of mice transgenic for hTNF alpha. Biochim Biophys Acta. 2005, 1734, 235-246.
10. C. Hohberg, G. Lubben, T. Forst, N. Marx, M. M. Weber, M. Lobig, A. Pfutzner: PPAR gamma stimulation improves cardiovascular risk profile independent from its glucose lowering effects. Diabetes. 2005, 54, A149-A150.
11. S. Luquet, C. Gaudel, D. Holst, J. Lopez-Soriano, C. Jehl-Pietri, A. Fredenrich, P. A. Grimaldi: Roles of PPAR delta in lipid absorption and metabolism: A new target for the treatment of type 2 diabetes. Biochim Biophys Acta. 2005, 1740, 313-317.
12. A. K. Duttaroy: Transport mechanisms for long-chain polyunsaturated fatty acids in the human placenta. Am J Clin Nutr. 2000, 71, 315S-322S.
13. P. Haggarty: Effect of placental function on fatty acid requirements during pregnancy. Eur J Clin Nutr. 2004, 58, 1559-1570.
14. S. M. Innis: Essential fatty acids in growth and development. Prog Lipid Res. 1991, 30, 39-103.
15. S. M. Innis: The role of dietary n-6 and n-3 fatty acids in the developing brain. Dev Neurosci. 2000, 22, 474-480.
16. S. M. Innis: Essential fatty acid transfer and fetal development. Placenta. 2005, 26 SupplA, S70-S75.
17. F. M. Campbell, P. G. Bush, J. H. Veerkamp, A. K. Duttaroy: Detection and cellular localization of plasma membrane-associated and cytoplasmic fatty acid-binding proteins in human placenta. Placenta. 1998, 19, 409-415.
18. B. I. Frohnert, T. Y. Hui, D. A. Bernlohr: Identification of a functional peroxisome proliferator-responsive element in the murine fatty acid transport protein gene. J Biol Chem. 1999, 274, 3970-3977.
19. N. M. Lapsys, A. D. Kriketos, M. Lim-Fraser, A. M. Poynten, A. Lowy, S. M. Furier, D. J. Chisholm, G. J. Cooney: Expression of genes involved in lipid metabolism correlate with peroxisome proliferator-activated receptor gamma expression in human skeletal muscle. J Clin Endocrinol Metab. 2000, 85, 4293-4297.
20. G. Martin, K. Schoonjans, A. M. Lefebvre, B. Staels, J. Auwerx: Coordinate regulation of the expression of the fatty acid transport protein and acyl-CoA synthetase genes by PPAR alpha and PPAR gamma activators. J Biol Chem. 1997, 272, 28210-28217.
21. K. Motojima, P. Passilly, J. M. Peters, F. J. Gonzalez, N. Latruffe: Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue- and inducer-specific manner. J Biol Chem. 1998, 273, 16710-16714.
22. K. Schoonjans, B. Staels, J. Auwerx: The peroxisome proliferator activated receptors (PPARs) and their effects on lipid metabolism and adipocyte differentiation. Biochim Biophys Acta. 1996, 1302, 93-109.
23. S. D. Clarke: Polyunsaturated fatty acid regulation of gene transcription: A molecular mechanism to improve the metabolic syndrome. J Nutr. 2001, 131, 1129-1132.
24. D. B. Jump: Fatty acid regulation of gene transcription. Crit Rev Clin Lab Sci. 2004, 41, 41-78.
25. A. K. Duttaroy: Fetal growth and development: Roles of fatty acid transport proteins and nuclear transcription factors in human placenta. Indian J Exp Biol. 2004, 42, 747-757.
26. T. Fournier, L. Pavan, A. Tarrade, K. Schoonjans, J. Auwerx, C. Rochette-Egly, D. Evain-Brion: The role of PPAR-gamma/RXR-alpha heterodimers in the regulation of human trophoblast invasion. Ann N Y Acad Sci. 2002, 973, 26-30.
27. A. Tarrade, K. Schoonjans, J. Guibourdenche, J. M. Bidart, M. Vidaud, J. Auwerx, C. Rochette-Egly, D. Evain-Brion: PPAR gamma/RXR alpha heterodimers are involved in human CG beta synthesis and human trophoblast differentiation. Endocrinology. 2001, 142, 4504-4514.
28. A. Chawla, J. J. Repa, R. M. Evans, D. J. Mangelsdor: Nuclear receptors and lipid physiology: Opening the X-files. Science. 2001, 294, 1866-1870.
29. J. D. Chen, R. M. Evans: A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature. 1995, 377, 454-457.
30. A. J. Horlein, A. M. Naar, T. Heinzel, J. Torchia, B. Gloss, R. Kurokawa, A. Ryan, Y. Kamei, M. Soderstrom, C. K. Glass: Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 1995, 377, 397-404.
31. M. Hadzopoulou-Cladaras, E. Kistanova, C. Evagelopoulou, S. Zeng, C. Cladaras, J. A. Ladias: Functional domains of the nuclear receptor hepatocyte nuclear factor 4. J Biol Chem. 1997, 272, 539-550.
32. M. D. Ruse, Jr., M. L. Privalsky, F. M. Sladek: Competitive cofactor recruitment by orphan receptor hepatocyte nuclear factor 4alpha1: Modulation by the F domain. Mol Cell Biol. 2002, 22, 1626-1638.
33. B. D. Darimont, R. L. Wagner, J. W. Apriletti, M. R. Stallcup, P. J. Kushner, J. D. Baxter, R. J. Fletterick, K. R. Yamamoto: Structure and specificity of nuclear receptor-coactivator interactions. Genes Dev. 1998, 12, 3343-3356.
34. R. Kurokawa, M. Soderstrom, A. Horlein, S. Halachmi, M. Brown, M. G. Rosenfeld, C. K. Glass: Polarity-specific activities of retinoic acid receptors determined by a corepressor. Nature. 1995, 377, 451-454.
35. E. Hu, J. B. Kim, P. Sarraf, B. M. Spiegelman: Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma. Science. 1996, 274, 2100-2103.
36. E. Soutoglou, N. Katrakili, I. Talianidis: Acetylation regulates transcription factor activity at multiple levels. Mol Cell. 2000, 5, 745-751.
37. M. G. Rosenfeld, C. K. Glass: Coregulator codes of transcriptional regulation by nuclear receptors. J Biol Chem. 2001, 276, 36865-36868.
38. T. Jenuwein, C. D. Allis: Translating the histone code. Science. 2001, 293, 1074-1080.
39. F. M. Gregoire, V. Rakhmanova, F. Zhang, Y. Zhu, J. Y. Ma, P. Cheng, S. Zhao, B. Lavan, T. A. Gustafson: Effects of novel PPAR delta, PPAR dual delta/gamma and PPAR delta/gamma/alpha (pan (TM)) agonists on PPAR-responsive genes in human adipocytes and macrophages. Diabetes. 2005, 54, A140.
40. T. Lemberger, R. Saladin, M. Vazquez, F. Assimacopoulos, B. Staels, B. Desvergne, W. Wahli, J. Auwerx: Expression of the peroxisome proliferator-activated receptor alpha gene is stimulated by stress and follows a diurnal rhythm. J Biol Chem. 1996, 271, 1764-1769.
41. O. Braissant, F. Foufelle, C. Scotto, M. Dauca, W. Wahli: Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology. 1996, 137, 354-366.
42. T. E. Cullingford, K. Bhakoo, S. Peuchen, C. T. Dolphin, R. Patel, J. B. Clark: Distribution of mRNAs encoding the peroxisome proliferator-activated receptor alpha, beta, and gamma and the retinoid X receptor alpha, beta, and gamma in rat central nervous system. J Neurochem. 1998, 70, 1366-1375.
43. S. A. Kliewer, B. M. Forman, B. Blumberg, E. S. Ong, U. Borgmeyer, D. J. Mangelsdorf, K. Umesono, R. M. Evans: Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc Natl Acad Sci USA. 1994, 91, 7355-7359.
44. T. Lemberger, O. Braissant, C. Juge-Aubry, H. Keller, R. Saladin, B. Staels, J. Auwerx, A. G. Burger, C. A. Meier, W. Wahli: PPAR tissue distribution and interactions with other hormone-signaling pathways. Ann N Y Acad Sci. 1996, 804, 231-251.
45. A. V. Ershov, N. G. Bazan: Photoreceptor phagocytosis selectively activates PPARgamma expression in retinal pigment epithelial cells. J Neurosci Res. 2000, 60, 328-337.
46. D. Auboeuf, J. Rieusset, L. Fajas, P. Vallier, V. Frering, J. P. Riou, B. Staels, J. Auwerx, M. Laville, H. Vidal: Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: No alteration in adipose tissue of obese and NIDDM patients. Diabetes. 1997, 46, 1319-1327.
47. R. Mukherjee, L. Jow, G. E. Croston and J. R. Paterniti, Jr.: Identification, characterization, and tissue distribution of human peroxisome proliferator-activated receptor (PPAR) isoforms PPARgamma2 versus PPARgamma1 and activation with retinoid X receptor agonists and antagonists. J Biol Chem. 1997, 272, 8071-8076.
48. K. W. Marvin, R. L. Eykholt, J. A. Keelan, T. A. Sato, M. D. Mitchell: The 15-deoxy-delta(12,14)-prostaglandin J(2)receptor, peroxisome proliferator activated receptor-gamma (PPARgamma) is expressed in human gestational tissues and is functionally active in JEG3 choriocarcinoma cells. Placenta. 2000, 21, 436-440.
49. P. Tontonoz, E. Hu, B. M. Spiegelman: Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 1994, 79, 1147-1156.
50. P. Tontonoz, E. Hu, R. A. Graves, A. I. Budavari, B. M. Spiegelman: PPAR gamma 2: Tissue-specific regulator of an adipocyte enhancer. Genes Dev. 1994, 8, 1224-1234.
51. P. Escher, W. Wahli: Peroxisome proliferator-activated receptors: Insight into multiple cellular functions. Mutat Res. 2000, 448, 121-138.
52. L. Fajas, D. Auboeuf, E. Raspe, K. Schoonjans, A. M. Lefebvre, R. Saladin, J. Najib, M. Laville, J. C. Fruchart, S. Deeb, A. Vidal-Puig, J. Flier, M. R. Briggs, B. Staels, H. Vidal, J. Auwerx: The organization, promoter analysis, and expression of the human PPARgamma gene. J Biol Chem. 1997, 272, 18779-18789.
53. L. Fajas, J. C. Fruchart, J. Auwerx: PPARgamma3 mRNA: A distinct PPARgamma mRNA subtype transcribed from an independent promoter. FEBS Lett. 1998, 438, 55-60.
54. J. Vamecq, N. Latruffe: Medical significance of peroxisome proliferator-activated receptors. Lancet. 1999, 354, 141-148.
55. C. N. Palmer, M. H. Hsu, A. S. Muerhoff, K. J. Griffin, E. F. Johnson: Interaction of the peroxisome proliferator-activated receptor alpha with the retinoid X receptor alpha unmasks a cryptic peroxisome proliferator response element that overlaps an ARP-1-binding site in the CYP4A6 promoter. J Biol Chem. 1994, 269, 18083-18089.
56. C. N. Palmer, M. H. Hsu, H. J. Griffin, E. F. Johnson: Novel sequence determinants in peroxisome proliferator signaling. J Biol Chem. 1995, 270, 16114-16121.
57. P. Targett-Adams, M. J. McElwee, E. Ehrenborg, M. C. Gustafsson, C. N. Palmer, J. McLauchlan: A PPAR response element regulates transcription of the gene for human adipose differentiation-related protein. Biochim Biophys Acta. 2005, 1728, 95-104.
58. J. C. Corton, S. P. Anderson, A. Stauber: Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators. Annu Rev Pharmacol Toxicol. 2000, 40, 491-518.
59. O. Wendung, P. Chambon, M. Mark: Retinoid X receptors are essential for early mouse development and placentogenesis. Proc Natl Acad Sci USA. 1999, 96, 547-551.
60. J. Keelan, R. Helliwell, B. Nijmeijer, E. Berry, T. Sato, K. Marvin, M. Mitchell, R. Gilmour: 15-Deoxy-delta12,14-prostaglandin J2-induced apoptosis in amnion-like WISH cells. Prostaglandins Lipid Mediat. 2001, 66, 265-282.
61. Q. Wang, D. Herrera-Ruiz, A. S. Mathis, T. J. Cook, R. K. Bhardwaj, G. T. Knipp: Expression of PPAR, RXR isoforms and fatty acid transporting proteins in the rat and human gastrointestinal tracts. J Pharm Sci. 2005, 94, 363-372.
62. S. S. Lee, T. Pineau, J. Drago, E. J. Lee, J. W. Owens, D. L. Kroetz, P. M. Fernandez-Salguero, H. Westphal, F. J. Gonzalez: Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol Cell Biol. 1995, 15, 3012-3022.
63. H. Matsuo, J. F. Strauss, III: Peroxisome proliferators and retinoids affect JEG-3 choriocarcinoma cell function. Endocrinology. 1994, 135, 1135-1145.
64. F. Hashimoto, Y. Oguchi, M. Morita, K. Matsuoka, S. Takeda, M. Kimura, H. Hayashi: PPARalpha agonists clofibrate and gemfibrozil inhibit cell growth, down-regulate hCG and upregulate progesterone secretions in immortalized human trophoblast cells. Biochem Pharmacol. 2004, 68, 313-321.
65. K. Hanley, Y. Jiang, D. Crumrine, N. M. Bass, R. Appel, P. M. Elias, M. L. Williams, K. R. Feingold: Activators of the nuclear hormone receptors PPARalpha and FXR accelerate the development of the fetal epidermal permeability barrier. J Clin Invest. 1997, 100, 705-712.
66. M. Schmuth, K. Schoonjans, Q. C. Yu, J. W. Fluhr, D. Crumrine, J. P. Hachem, P. Lau, J. Auwerx, P. M. Elias, K. R. Feingold: Role of peroxisome proliferator-activated receptor alpha in epidermal development in utero. J Invest Dermatol. 2002, 119, 1298-1303.
67. N. Kubota, Y. Terauchi, H. Miki, H. Tamemoto, T. Yamauchi, K. Komeda, S. Satoh, R. Nakano, C. Ishii, T. Sugiyama, K. Eto, Y. Tsubamoto, A. Okuno, K. Murakami, H. Sekihara, G. Hasegawa, M. Naito, Y. Toyoshima, S. Tanaka, K. Shiota, T. Kitamura, T. Fujita, O. Ezaki, S. Aizawa, T. Kadowaki: PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell. 1999, 4, 597-609.
68. S. E. Crawford, C. Qi, P. Misra, V. Stellmach, M. S. Rao, J. D. Engel, Y. Zhu, K. Reddy: Defects of the heart, eye, and megakaryocytes in peroxisome proliferator activator receptor-binding protein (PBP) null embryos implicate GATA family of transcription factors. J Biol Chem. 2002, 277, 3585-3592.
69. Y. J. Zhu, S. E. Crawford, V. Stellmach, R. S. Dwivedi, M. S. Rao, F. J. Gonzalez, C. Qi, J. K. Reddy: Coactivator PRIP, the peroxisome proliferator-activated receptor-interacting protein, is a modulator of placental, cardiac, hepatic, and embryonic development. J Biol Chem. 2003, 278, 1986-1990.
70. Y. Cui, K. Miyoshi, E. Claudio, U. K. Siebenlist, F. J. Gonzalez, J. Flaws, K. U. Wagner, L. Hennighausen: Loss of the peroxisome proliferation-activated receptor gamma (PPAR-gamma) does not affect mammary development and propensity for tumor formation but leads to reduced fertility. J Biol Chem. 2002, 277, 17830-17835.
71. G. G. Daoud, L. Simoneau, A. Masse, E. Rassart, J. Lafond: Expression of cFABP and PPAR in trophoblast cells: Effect of PPAR ligands on linoleic acid uptake and differentiation. Biochim Biophys Acta. 2005, 1687, 181-194.
72. A. K. Duttaroy, D. Crozet, J. Taylor, M. J. Gordon: Acyl-CoA thioesterase activity in human placental choriocarcinoma (BeWo) cells: Effects of fatty acids. Prostaglandins Leukot Essent Fatty Acids. 2003, 68, 43-48.
73. W. T. Schaiff, M. G. Carlson, S. D. Smith, R. Levy, D. M. Nelson, Y. Sadovsky: Peroxisome proliferator-activated receptor-gamma modulates differentiation of human trophoblast in a ligand-specific manner. J Clin Endocrinol Metab. 2000, 85, 3874-3881.
74. J. H. Lee, H. S. Kim, S. Y. Jeong, I. K. Kim: Induction of p53 and apoptosis by delta 12-PGJ2 in human hepatocarcinoma SK-HEP-1 cells. FEBS Lett. 1995, 368, 348-352.
75. G. Eibl, M. N. Wente, H. A. Reber, O. J. Hines: Peroxisome proliferator-activated receptor gamma induces pancreatic cancer cell apoptosis. Biochem Biophys Res Commun. 2001, 287, 522-529.
76. Y. Tsubouchi, H. Sano, Y. Kawahito, S. Mukai, R. Yamada, M. Kohno, K. Inoue, T. Hla, M. Kondo: Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor-gamma agonists through induction of apoptosis. Biochem Biophys Res Commun. 2000, 270, 400-405.
77. E. J. Kim, K. S. Park, S. Y. Chung, Y. Y. Sheen, D. C. Moon, Y. S. Song, K. S. Kim, S. Song, Y. P. Yun, M. K. Lee, K. W. Oh, D. Y. Yoon, J. T. Hong: Peroxisome proliferator-activated receptor-gamma activator 15-deoxy-Delta12,14- prostaglandin J2 inhibits neuroblastoma cell growth through induction of apoptosis: Association with extracellular signal-regulated kinase signal pathway. J Pharmacol Exp Ther. 2003, 307, 505-517.
78. D. Evain-Brion, T. Fournier, P. Therond, A. Tarrade, L. Pavan: Pathogenesis of pre-eclampsia: Role of gamma PPAR in trophoblast invasion. Bull Acad Natl Med. 2002, 186, 409-418.
79. L. L. Waite, E. C. Person, Y. Zhou, K. H. Lim, T. S. Scanlan, R. N. Taylor: Placental peroxisome proliferator-activated receptor-gamma is up-regulated by pregnancy serum. J Clin Endocrinol Metab. 2000, 85, 3808-3814.
80. R. L. Schild, W. T. Schaiff, M. G. Carlson, E. J. Cronbach, D. M. Nelson, Y. Sadovsky: The activity of PPAR gamma in primary human trophoblasts is enhanced by oxidized lipids. J Clin Endocrinol Metab. 2002, 87, 1105-1110.
81. L. A. Moraes, L. Piqueras, D. Bishop-Bailey: Peroxisome proliferator-activated receptors and inflammation. Pharmacol Ther. 2005 (epub).
82. B. Staels, W. Koenig, A. Habib, R. Merval, M. Lebret, I. P. Torra, P. Delerive, A. Fadel, G. Chinetti, J. C. Fruchart, J. Najib, J. Maclouf, A. Tedgui: Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators. Nature. 1998, 393, 790-793.
83. Q. Wang, H. Fujii, G. T. Knipp: Expression of PPAR and RXR isoforms in the developing rat and human term placentas. Placenta. 2002, 23, 661-671.
84. Y. Barak, D. Liao, W. He, E. S. Ong, M. C. Nelson, J. M. Olefsky, R. Boland, R. M. Evans: Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer. Proc Natl Acad Sci USA. 2002, 99, 303-308.
85. L. Julan, H. Guan, J. P. van Beek, K. Yang: Peroxisome proliferator-activated receptor delta suppresses 11 beta-hydroxysteroid dehydrogenase type 2 gene expression in human placental trophoblast cells. Endocrinology. 2005, 146, 1482-1490.
86. K. Yang: Placental 11 beta-hydroxysteroid dehydrogenase: Barrier to maternal glucocorticoids. Rev Reprod. 1997, 2, 129-132.
87. H. Lim, S. K. Dey: PPAR delta functions as a prostacyclin receptor in blastocyst implantation. Trends Endocrinol Metab. 2000, 11, 137-142.
88. P. A. Scherle, W. Ma, H. Lim, S. K. Dey, J. M. Trzaskos: Regulation of cyclooxygenase-2 induction in the mouse uterus during decidualization. An event of early pregnancy. J Biol Chem. 2000, 275, 37086-37092.
89. R. J. Helliwell, E. B. Berry, S. J. O'Carroll, M. D. Mitchell: Nuclear prostaglandin receptors: Role in pregnancy and parturition? Prostaglandins Leukot Essent Fatty Acids. 2004, 70, 149-165.
90. C. C. Song, R. A. Hiipakka, S. Liao: Selective activation of liver X receptor alpha by 6alpha-hydroxy bile acids and analogs. Steroids. 2000, 65, 423-427.
91. P. J. Willy, K. Umesono, E. S. Ong, R. M. Evans, R. A. Heyman, D. J. Mangelsdorf: LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev. 1995, 9, 1033-1045.
92. J. M. Lehmann, S. A. Kliewer, L. B. Moore, T. A. Smith-Oliver, B. B. Oliver, J. L. Su, S. S. Sundseth, D. A. Winegar, D. E. Blanchard, T. A. Spencer, T. M. Willson: Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J Biol Chem. 1997, 272, 3137-3140.
93. S. M. Ulven, H. I. Nebb: Liver X receptors (LXRs): Important regulators of lipid homeostasis. In: Cellular Proteins and Their Fatty Acids in Health and Disease. Eds. A. K. Duttaroy, F. Spener, VCH-Wiley, Weinheim (Germany) 2003, pp. 209-220.
94. A. Venkateswaran, B. A. Laffitte, S. B. Joseph, P. A. Mak, D. C. Wilpitz, P. A. Edwards, P. Tontonoz: Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha. Proc Natl Acad Sci USA. 2000, 97, 12097-12102.
95. M. S. Weedon-Fekjaer, A. K. Duttaroy, H. I. Nebb: Liver X receptors mediate inhibition of hCG secretion in a human placental trophoblast cell line. Placenta. 2005, 26, 721-728.
96. H. Shimano: Sterol regulatory element-binding proteins (SREBPs): Transcriptional regulators of lipid synthetic genes. Prog Lipid Res. 2001, 40, 439-452.
97. L. Pavan, A. Hermouet, V. Tsatsaris, P. Therond, T. Sawamura, D. Evain-Brion, T. Fournier: Lipids from oxidized low-density lipoprotein modulate human trophoblast invasion: Involvement of nuclear liver X receptors. Endocrinology. 2004, 145, 4583-4591.
98. P. Haggarty: Placental regulation of fatty acid delivery and its effect on fetal growth - a review. Placenta. 2002, 23 Suppl A, S28-S38.
99. A. K. Duttaroy: Cellular uptake of long-chain fatty acids: Role of membrane-associated fatty-acid-binding/transport proteins. Cell Mol Life Sci. 2000, 57, 1360-1372.
100. F. M. Campbell, A. K. Duttaroy: Plasma-membrane fatty-acid-binding protein (FABPpm)) is exclusively located in the maternal facing membranes of the human placenta. FEBS Lett. 1995, 375, 227-230.
101. J. F. C. Glatz, J. J. F. P. Luiken, A. Bonen: Involvement of membrane-associated proteins in the acute regulation of cellular fatty acid uptake. J Mol Neurosci. 2001, 16, 123-132.
102. F. M. Campbell, M. J. Gordon, A. K. Duttaroy, Preferential uptake of long chain polyunsaturated fatty acids by isolated human placental membranes. Mol Cell Biochem. 1996, 155, 77-83.
103. A. K. Duttaroy, N. Gopalswamy, D. V. Trulzsch: Prostaglandin-E1 binds to Z-protein of rat liver. Eur J Biochem. 1987, 162, 615-619.
104. R. A. Peeters, M. A. in't Groen, M. P. de Moel, H. T. van Moerkerk, J. H. Veerkamp: The binding affinity of fatty acid-binding proteins from human, pig and rat liver for different fluorescent fatty acids and other ligands. Int J Biochem. 1989, 21, 407-418.
105. J. H. Veerkamp, H. T. van Moerkerk, C. F. Prinsen, T. H. van Kuppevelt: Structural and functional studies on different human FABP types. Mol Cell Biochem. 1999, 192, 137-142.
106. A. W. Zimmerman, H. T. van Moerkerk, J. H. Veerkamp: Ligand specificity and conformational stability of human fatty acid-binding proteins. Int J Biochem Cell Biol. 2001, 33, 865-876.
107. C. Wolfrum, T. Borchers, J. C. Sacchettini, F. Spener: Binding of fatty acids and peroxisome proliferators to orthologous fatty acid binding proteins from human, murine, and bovine liver. Biochemistry. 2000, 39, 14363-14370.
108. C. Wolfrum, C. M. Borrmann, T. Borchers, F. Spener: Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors alpha - and gamma-mediated gene expression via liver fatty acid binding protein: A signaling path to the nucleus. Proc Natl Acad Sci USA. 2001, 98, 2323-2328.
109. E. J. Murphy, D. R. Prows, J. R. Jefferson, F. Schroeder: Liver fatty acid-binding protein expression in transfected fibroblasts stimulates fatty acid uptake and metabolism. Biochim Biophys Acta. 1996, 1301, 191-198.
110. J. C. Fruchart, P. Duriez, B. Staels: Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis. Curr Opin Lipidol. 1999, 10, 245-257.
111. B. D. Hegarty, S. M. Furler, N. D. Oakes, E. W. Kraegen, G. J. Cooney: Peroxisome proliferator-activated receptor (PPAR) activation induces tissue-specific effects on fatty acid uptake and metabolism in vivo - a study using the novel PPARalpha/gamma agonist tesaglitazar. Endocrinology. 2004, 145, 3158-3164.
112. B. Staels, J. Dallongeville, J. Auwerx, K. Schoonjans, E. Leitersdorf, J. C. Fruchart: Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation. 1998, 98, 2088-2093.
113. Y. Tamori, J. Masugi, N. Nishino, M. Kasuga: Role of peroxisome proliferator-activated receptor-gamma in maintenance of the characteristics of mature 3T3-L1 adipocytes. Diabetes. 2002, 51, 2045-2055.
114. W. T. Schaiff, I. Bildirici, M. Cheong, P. L. Chern, D. M. Nelson, Y. Sadovsky: Peroxisome proliferator-activated receptor-gamma and retinoid X receptor signaling regulate fatty acid uptake by primary human placental trophoblasts. J Clin Endocrinol Metab. 2005, 90, 4267-4275.
115. I. Bildirici, C. R. Roh, W. T. Schaiff, B. M. Lewkowski, D. M. Nelson, Y. Sadovsky: The lipid droplet-associated protein adipophilin is expressed in human trophoblasts and is regulated by peroxisomal proliferator-activated receptor-gamma/retinoid X receptor. J Clin Endocrinol Metab. 2003, 88, 6056-6062.
116. I. Issemann, S. Green: Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature. 1990, 347, 645-650.
117. K. Ohta, T. Endo, K. Haraguchi, J. M. Hershman, T. Onaya: Ligands for peroxisome proliferator-activated receptor gamma inhibit growth and induce apoptosis of human papillary thyroid carcinoma cells. J Clin Endocrinol Metab. 2001, 86, 2170-2177.
118. B. H. Rovin, W. A. Wilmer, L. Lu, A. I. Doseff, C. Dixon, M. Kotur, T. Hilbelink: 15-Deoxy-Delta12,14-prostaglandin J2 regulates mesangial cell proliferation and death. Kidney Int. 2002, 61, 1293-1302.
119. J. R. G. Challis, S. J. Lye: Parturition. In: The Physiology of Reproduction. Eds. E. Knobill, J. D. Neill, Raven Press, New York (USA) 1994, pp. 985-1031.
120. M. D. Mitchell, D. L. Kraemer, D. M. Strickland: The human placenta: A major source of prostaglandin D2. Prostaglandins Leukot Med. 1982, 8, 383-387.
121. M. D. Mitchell, C. F. Grzyboski: Arachidonic acid metabolism by lipoxygenase pathways in intrauterine tissues of women at term of pregnancy. Prostaglandins Leukot Med. 1987, 28, 303-312.
122. A. K. Duttaroy, N. N. Kahn, A. K. Sinha: Interaction of receptors for prostaglandin-E1, prostacyclin and insulin in human erythrocytes and platelets. Life Sci. 1991, 49, 1129-1139.
123. A. K. Duttaroy: Insulin-mediated processes in platelets, erythrocytes and monocytes macrophages - effects of essential fatty-acid metabolism. Prostaglandins Leukot Essent Fatty Acids. 1994, 51, 385-399.
124. J. A. Keelan, T. A. Sato, K. W. Marvin, J. Lander, R. S. Gilmour, M. D. Mitchell: 15-Deoxy-Delta(12,14)-prostaglandin J(2), a ligand for peroxisome proliferator-activated receptor-gamma, induces apoptosis in JEG3 choriocarcinoma cells. Biochem Biophys Res Commun. 1999, 262, 579-585.
125. T. Shibata, M. Kondo, T. Osawa, N. Shibata, M. Kobayashi, K. Uchida: 15-Deoxy-delta 12,14-prostaglandin J2. A prostaglandin 14;D2 metabolite generated during inflammatory processes. J Biol Chem. 2002, 277, 10459-10466.
126. G. Ferry, V. Bruneau, P. Beauverger, M. Goussard, M. Rodriguez, V. Lamamy, S. Dromaint, E. Canet, J. P. Galizzi, J. A. Boutin: Binding of prostaglandins to human PPAR-gamma: Tool assessment and new natural ligands. Eur J Pharmacol. 2001, 417, 77-89.
127. K. J. Lee, H. A. Kim, P. H. Kim, H. S. Lee, K. R. Ma, J. H. Park, D. J. Kim, J. H. Hahn: Ox-LDL suppresses PMA-induced MMP-9 expression and activity through CD36-mediated activation of PPARγ. Exp Mol Med. 2004, 36, 534-544.
128. 1/prostacyclin receptor of human-blood platelets. J Biol Chem. 1987, 262, 12685-12691.
129. T. Hatae, M. Wada, C. Yokoyama, M. Shimonishi, T. Tanabe: Prostacyclin-dependent apoptosis mediated by PPAR delta. J Biol Chem. 2001, 276, 46260-46267.
130. F. R. Homaidan, I. Chakroun, H. A. Haidar, M. E. El Sabban: Protein regulators of eicosanoid synthesis: Role in inflammation. Curr Protein Pept Sci. 2002, 3, 467-484.
131. T. G. Brock, E. Maydanski, R. W. McNish, M. Peters-Golden: Co-localization of leukotriene a4 hydrolase with 5-lipoxygenase in nuclei of alveolar macrophages and rat basophilic leukemia cells but not neutrophils. J Biol Chem. 2001, 276, 35071-35077.
132. P. R. Devchand, H. Keller, J. M. Peters, M. Vazquez, F. J. Gonzalez, W. Wahli: The PPARalpha-leukotriene B4 pathway to inflammation control. Nature. 1996, 384, 39-43.
133. P. R. Devchand, A. K. Hihi, M. Perroud, W. D. Schleuning, B. M. Spiegelman, W. Wahli: Chemical probes that differentially modulate peroxisome proliferator-activated receptor alpha and BLTR, nuclear and cell surface receptors for leukotriene B(4). J Biol Chem. 1999, 274, 23341-23348.
134. S. S. Edwin, S. L. LaMarche, D. Thai, D. W. Branch, M. D. Mitchell: 5-Hydroxyeicosatetraenoic acid biosynthesis by gestational tissues: Effects of inflammatory cytokines. Am J Obstet Gynecol. 1993, 169, 1467-1471.
135. S. S. Edwin, M. D. Mitchell: Arachidonate lipoxygenase metabolite formation in gestational tissues. J Lipid Mediat Cell Signal. 1994, 9, 291-300.
136. S. S. Edwin, D. Thai, S. LaMarche, D. W. Branch, M. D. Mitchell: The regulation of arachidonate lipoxygenase metabolite formation in cells derived from intrauterine tissues. Prostaglandins Leukot Essent Fatty Acids. 1995, 52, 229-233.
137. S. S. Edwin, R. J. Romero, H. Munoz, D. W. Branch, M. D. Mitchell: 5-Hydroxyeicosatetraenoic acid and human parturition. Prostaglandins. 1996, 51, 403-412.
138. S. S. Edwin, M. D. Mitchell, D. J. Dudley: Action of immunoregulatory agents on 5-HETE production by cultured human amnion cells. J Reprod Immunol. 1997, 36, 111-121.
139. B. A. Lopez, D. J. Hansell, T. Y. Khong, J. W. Keeling, A. C. Turnbull: Placental leukotriene B4 release in early pregnancy and in term and preterm labour. Early Hum Dev. 1990, 23, 93-99.
140. R. Romero, Y. K. Wu, M. Mazor, J. C. Hobbins, M. D. Mitchell: Amniotic fluid concentration of 5-hydroxyeicosatetraenoic acid is increased in human parturition at term. Prostaglandins Leukot Essent Fatty Acids. 1989, 35, 81-83.
141. B. M. Forman, J. Chen, R. M. Evans: Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc Natl Acad Sci USA. 1997, 94, 4312-4317.
142. K. Yu, W. Bayona, C. B. Kallen, H. P. Harding, C. P. Ravera, G. McMahon, M. Brown, M. A. Lazar: Differential activation of peroxisome proliferator-activated receptors by eicosanoids. J Biol Chem. 1995, 270, 23975-23983.
143. A. K. Duttaroy, A. Jørgensen: Insulin and leptin do not affect fatty acid uptake and metabolism in human placental choriocarcinoma (BeWo) cells. Prostaglandins Leukot Essent Fatty Acids. 2005, 72, 403-408.
144. L. L. Waite, R. E. Louie, R. N. Taylor: Circulating activators of peroxisome proliferator-activated receptors are reduced in preeclamptic pregnancy. J Clin Endocrinol Metab. 2005, 90, 620-626.